Skip to content
Top Globe News – Lifestyle
Author:
BioNTech SE
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
May 5, 2026
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
April 28, 2026
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
April 11, 2026
←
Previous Page
1
2